Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Head-to-head · AI Drug Discovery Software

Iktos vs Xaira platform

  • Updated Oct 2026
  • Both researched from official sources
  • 3 checks side by side
Higher score Iktos #5 in AI Drug Discovery Software 7.9/10 Pricing on request ✓ 3 of 4 features Visit Iktos
Xaira platform #8 in AI Drug Discovery Software 7.6/10 Pricing on request ✓ 3 of 4 features Contact Xaira

Iktos leads on 0 checks, Xaira platform on 0, and 3 are even. Who comes out ahead on the 3 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scoreIktos · 7.9/10

Iktos scores higher on our rubric for ai drug discovery software: 7.9 against 7.6 out of 10; our editors rank them #5 and #8.

Iktos is the better fit for teams combining molecular design with automated testing. Xaira platform is the better fit for enterprise teams combining AI discovery with robotic labs.

  • Iktos fits best

    Teams combining molecular design with automated testing

  • Xaira platform fits best

    Enterprise teams combining AI discovery with robotic labs

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Side by side

Feature Iktos 7.9/10 Visit ↗ Xaira platform 7.6/10 Visit ↗
At a glance
Editor score 7.9 7.6
Ranking #5 in AI Drug Discovery Software #8 in AI Drug Discovery Software
Best for Teams combining molecular design with automated testing Enterprise teams combining AI discovery with robotic labs
Pricing model Paid Paid
Starting price Pricing on request Pricing on request
Free plan Not checked yet Not checked yet
Free trial — —
Built for Mid-market, Enterprise Enterprise
Features Iktos 3/4 · Xaira platform 3/4
Target identification ✓ ✓
Molecule design ✓ ✓
Drug repurposing Not checked yet Not checked yet
Research publications ✓ ✓
Specs
Discovery scope Suite Suite
Deployment options Both Not checked yet
Our review
Pros
  • Generates molecules against target product profile constraints
  • Combines SAR, ADMET, and multi-parameter compound scoring
  • Connects design with automated synthesis and biological testing workflows
  • Connects target discovery, molecule design and patient-response modeling
  • Coordinates discovery workflows with a multi-agent AI research system
  • Feeds automated lab results back into model development
Cons
  • Pricing is available through contact sales
  • The listed support channel is email
  • The platform's components and workflows may call for specialist drug-discovery teams
  • The published offering is not presented as standalone subscription software
  • Pricing is handled through contact sales
  • Current molecule-design focus is antibodies and proteins
Our verdict

Iktos brings molecule design, retrosynthesis, and laboratory automation into a drug-discovery suite for pharmaceutical, biotech, and academic teams. Makya supports ligand- and structure-based molecular modeling, with target product profile…

Read the review →

Xaira platform brings computational drug discovery and laboratory experimentation into one system, aimed at enterprise teams developing therapeutics. Its components address several stages of research: X-Cell analyzes cellular perturbation…

Read the review →
  1. IktosAI Drug Discovery Software 7.9Pricing on request
  2. Xaira platformAI Drug Discovery Software 7.6Pricing on request

Strengths and trade-offs

  • Iktos — where it wins

    • Generates molecules against target product profile constraints
    • Combines SAR, ADMET, and multi-parameter compound scoring
    • Connects design with automated synthesis and biological testing workflows

    Where it doesn't

    • Pricing is available through contact sales
    • The listed support channel is email
    • The platform's components and workflows may call for specialist drug-discovery teams
  • Xaira platform — where it wins

    • Connects target discovery, molecule design and patient-response modeling
    • Coordinates discovery workflows with a multi-agent AI research system
    • Feeds automated lab results back into model development

    Where it doesn't

    • The published offering is not presented as standalone subscription software
    • Pricing is handled through contact sales
    • Current molecule-design focus is antibodies and proteins
  • Iktos7.9/10 · Pricing on request

    A drug-discovery suite linking constrained molecule design to automated synthesis and testing.

    Visit IktosFull verdict →
  • Xaira platform7.6/10 · Pricing on request

    A connected discovery suite linking AI models, research agents and robotic lab work.

    Contact XairaFull verdict →

More comparisons

Guides on AI drug discovery software

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Last updated · How we research and update